What side effects, aside from thrombosis and edema, are characteristic of estrogen medications?

Estrogen therapies commonly cause gastrointestinal, central nervous system, and reproductive side effects. Gastrointestinal symptoms include nausea, vomiting, and anorexia. The central nervous system may respond with exacerbated migraines and mood changes. In the reproductive system, breast tenderness and enlargement are frequently observed.

Beyond clotting factors, the synthesis of which plasma transport proteins do estrogens increase?

Estrogens stimulate hepatic synthesis, increasing the levels of specific plasma transport proteins, such as thyroxine-binding globulin (TBG). Elevated TBG directly alters total thyroxine measurements, raising its levels during estrogen or systemic hormonal contraceptive use.

What are the absolute contraindications to prescribing female sex hormone medications?

Absolute contraindications for menopausal hormone therapy include undiagnosed genital bleeding, endometrial polyps, submucosal uterine fibroids, breast cancer, estrogen-dependent malignancies of the endometrium, ovaries, or uterus, malignant liver tumors, acute or chronic liver disease until liver function tests normalize, arterial and venous thrombosis/thromboembolism, myocardial infarction, cerebrovascular events, high-risk inherited thrombophilias, antiphospholipid syndrome, cutaneous porphyria, and drug hypersensitivity. Other contraindications include a high risk of deep vein thrombosis or pulmonary embolism, uncontrolled hypertension, and patient preference against hormone therapy.

Which pharmacological agents belong to the antiestrogen group?

Anti-estrogenic drugs include selective estrogen receptor modulators (SERMs) and receptor blockers. SERMs include tamoxifen and toremifene, which exhibit mixed agonist/antagonist properties depending on the tissue. Fulvestrant is the sole estrogen receptor blocker, acting as a pure antagonist.

How do steroid hormones protect bone tissue from destruction?

They directly stimulate osteoblasts and suppress osteoclast activity. Additionally, they inhibit the effects of parathyroid hormone (PTH), preventing calcium mobilization and leaching from the bones.

Why do patients frequently develop edema during exogenous estrogen therapy?

These drugs promote fluid shifts from blood vessels into tissues, reducing circulating blood volume (CBV). The body compensates by releasing aldosterone and ADH, which retain sodium and water.

How is the anti-atherosclerotic effect of these hormones mediated?

Hormones bind to specific estrogen receptors on hepatocytes in the liver, normalizing lipoprotein metabolism: HDL levels increase and LDL levels decrease.

How does hormone therapy affect the risk of thrombosis?

The risk of thrombosis increases substantially. Hormones activate hepatic synthesis, increasing fibrinogen production and stimulating vitamin K-dependent clotting factors (II, IX, X).

Home › Pharmacology › Effects of Steroid Hormones

Effects of Steroid Hormones

*Hormona steroidea*

For medical students2 min readUpdated 2026-10-10

Steroid hormones (specifically female sex hormones) exert powerful systemic effects on the human body that extend far beyond the regulation of reproductive functions alone. Pharmacologically, they govern complex metabolic processes: regulating lipid metabolism, maintaining bone density and structure, directly influencing the blood coagulation system, and controlling water and electrolyte balance. Understanding these multifaceted mechanisms is clinically crucial for predicting both desired therapeutic outcomes and potential adverse effects of hormone therapy.

OsteogenesisIncrease bone mass and promote epiphyseal plate closure in both sexes.

HemostasisActivate the synthesis of fibrinogen and factors II, IX, and X, significantly increasing the risk of thrombosis.

Lipid ProfileExert an anti-atherosclerotic effect: increase HDL levels and decrease LDL concentration.

ReceptorsTrigger up-regulation: activate the synthesis of progesterone receptors and increase tissue sensitivity.

Fluid BalanceDecrease circulating blood volume (CBV), triggering a compensatory release of aldosterone and ADH, leading to water retention.

Reproductive System and Hormonal Interaction

In the female body, steroid hormones act as primary regulators of development, ensuring timely puberty and the full formation of secondary sexual characteristics. These hormones exhibit pronounced organotropic action: they purposefully stimulate the growth and development of the vagina, uterus, and fallopian tubes. In the mammary glands, they activate ductal growth and the surrounding stroma. Additionally, they tightly control the menstrual cycle, ensure ovulation, and thoroughly prepare the endometrium and other reproductive tract organs for successful fertilization and subsequent embryo implantation.

A critical pharmacodynamic feature is their interaction with progesterone via up-regulation. Estrogens actively stimulate the synthesis of specific progesterone receptors, thereby significantly increasing target tissue sensitivity to this hormone.

Effects on Bone Tissue

Steroids play a fundamental role in osteogenesis, an effect critical for both sexes. Their primary systemic action consists of significantly increasing bone mass and ensuring the timely closure of epiphyseal growth plates in bones.

At the cellular level, this process occurs through specific receptors located on bone cells. The hormones stimulate the activity of osteoblasts (cells that synthesize the bone matrix) while simultaneously suppressing the function of osteoclasts (bone-resorbing cells).

An additional mechanism for maintaining bone density is hormonal interaction. Steroids inhibit the effects of parathyroid hormone (PTH). Reducing PTH activity reliably prevents the pathological mobilization (leaching) of calcium ions from bone tissue into the blood.

Metabolic and Vascular Effects

These hormones produce a clinically significant anti-atherosclerotic effect. This mechanism is based on direct action on estrogen receptors located on hepatocyte membranes (liver cells), which regulate lipoprotein metabolism. As a result, the blood lipid profile improves: HDL ("good" cholesterol) levels reliably increase, while atherogenic LDL ("bad" cholesterol) concentrations decrease.

Beyond lipid metabolism, these hormones actively influence vascular tone. Their key vascular effect is transient vasodilation (widening of blood vessel lumens). This reaction is mediated by the rapid induction of nitric oxide (NO) production, a potent endogenous vasodilator.

Hemostasis and Water-Electrolyte Balance

The administration of exogenous steroid medications requires strict monitoring due to their impact on vital body systems:

Hemostatic system. Hormones enhance the synthetic function of the liver, notably activating fibrinogen production. Simultaneously, they stimulate the synthesis of vitamin K-dependent clotting factors (factors II, IX, and X). Consequently, blood coagulability increases markedly, manifesting clinically as a high risk of thrombosis.
Fluid and electrolyte balance. The pathogenesis of fluid retention develops as a cascade. First, hormones promote the shift of fluid from the vascular bed into surrounding interstitial tissues, predictably lowering the circulating blood volume (CBV). In response to decreased CBV, the body initiates a compensatory release of aldosterone and antidiuretic hormone (ADH). These substances stimulate active sodium and water reabsorption in the kidneys. Therefore, exogenous estrogen administration frequently triggers clinically apparent edema.

Mnemonic

To remember the effects, use the rule "PRO": PROliferation (growth of the uterus, vagina, and ducts), PROtective bone strength (increased bone mass, PTH block), PROpass (vasodilation via NO), PROthrombin (increase in clotting factors — risk of thrombosis), PROgesterone receptors (up-regulation of receptors).

Frequently asked questions

What side effects, aside from thrombosis and edema, are characteristic of estrogen medications?: Estrogen therapies commonly cause gastrointestinal, central nervous system, and reproductive side effects. Gastrointestinal symptoms include nausea, vomiting, and anorexia. The central nervous system may respond with exacerbated migraines and mood changes. In the reproductive system, breast tenderness and enlargement are frequently observed.
Beyond clotting factors, the synthesis of which plasma transport proteins do estrogens increase?: Estrogens stimulate hepatic synthesis, increasing the levels of specific plasma transport proteins, such as thyroxine-binding globulin (TBG). Elevated TBG directly alters total thyroxine measurements, raising its levels during estrogen or systemic hormonal contraceptive use.
What are the absolute contraindications to prescribing female sex hormone medications?: Absolute contraindications for menopausal hormone therapy include undiagnosed genital bleeding, endometrial polyps, submucosal uterine fibroids, breast cancer, estrogen-dependent malignancies of the endometrium, ovaries, or uterus, malignant liver tumors, acute or chronic liver disease until liver function tests normalize, arterial and venous thrombosis/thromboembolism, myocardial infarction, cerebrovascular events, high-risk inherited thrombophilias, antiphospholipid syndrome, cutaneous porphyria, and drug hypersensitivity. Other contraindications include a high risk of deep vein thrombosis or pulmonary embolism, uncontrolled hypertension, and patient preference against hormone therapy.
Which pharmacological agents belong to the antiestrogen group?: Anti-estrogenic drugs include selective estrogen receptor modulators (SERMs) and receptor blockers. SERMs include tamoxifen and toremifene, which exhibit mixed agonist/antagonist properties depending on the tissue. Fulvestrant is the sole estrogen receptor blocker, acting as a pure antagonist.
How do steroid hormones protect bone tissue from destruction?: They directly stimulate osteoblasts and suppress osteoclast activity. Additionally, they inhibit the effects of parathyroid hormone (PTH), preventing calcium mobilization and leaching from the bones.
Why do patients frequently develop edema during exogenous estrogen therapy?: These drugs promote fluid shifts from blood vessels into tissues, reducing circulating blood volume (CBV). The body compensates by releasing aldosterone and ADH, which retain sodium and water.
How is the anti-atherosclerotic effect of these hormones mediated?: Hormones bind to specific estrogen receptors on hepatocytes in the liver, normalizing lipoprotein metabolism: HDL levels increase and LDL levels decrease.
How does hormone therapy affect the risk of thrombosis?: The risk of thrombosis increases substantially. Hormones activate hepatic synthesis, increasing fibrinogen production and stimulating vitamin K-dependent clotting factors (II, IX, X).

Go deeper

Cellular mechanisms of osteoblast stimulation and osteoclast inhibition.
The role of nitric oxide (NO) in transient vasodilation.
Biosynthesis of vitamin K-dependent clotting factors in the liver.
Pathogenesis of aldosterone and ADH activation in response to reduced circulating blood volume.
Molecular basis of progesterone receptor up-regulation.